A detailed history of Procyon Advisors, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Procyon Advisors, LLC holds 3,241 shares of BSX stock, worth $316,904. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,241
Previous 4,765 31.98%
Holding current value
$316,904
Previous $480,000 27.5%
% of portfolio
0.03%
Previous 0.03%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 09, 2025

SELL
$89.7 - $107.41 $136,702 - $163,692
-1,524 Reduced 31.98%
3,241 $348,000
Q1 2025

Apr 11, 2025

BUY
$89.38 - $106.18 $217,550 - $258,442
2,434 Added 104.42%
4,765 $480,000
Q4 2024

Jan 15, 2025

BUY
$83.62 - $91.5 $194,918 - $213,286
2,331 New
2,331 $208,000
Q3 2020

Oct 22, 2020

SELL
$34.44 - $42.23 $15,670 - $19,214
-455 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$30.19 - $39.11 $12,891 - $16,699
427 Added 1525.0%
455 $16,000
Q4 2019

Feb 21, 2020

BUY
$37.87 - $45.37 $1,060 - $1,270
28 New
28 $1,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $140B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Procyon Advisors, LLC Portfolio

Follow Procyon Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Procyon Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Procyon Advisors, LLC with notifications on news.